LICENSE AGREEMENTLicense Agreement • May 13th, 2022 • Pyxis Oncology, Inc. • Pharmaceutical preparations • New York
This LICENSE AGREEMENT (“Agreement”) is made effective as of March 28, 2022 (the “Effective Date”), by and between Pyxis Oncology, Inc., a Delaware corporation, having an address at 35 Cambridge Park Drive, Cambridge, Massachusetts 02140 (“Licensee”), and Biosion USA, Inc., a Delaware corporation, having an address at 1 Innovation Way, Suite 300, Newark, Delaware 19711 (“Licensor”). Licensee and Licensor may, from time-to-time, be individually referred to as a “Party” and collectively referred to as the “Parties”.
